Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Urinary Bladder Neoplasms 1Solid Tumors 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Neoplasms 1Lymphoma, Mantle-Cell 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Burkitt Lymphoma 1

Interventions

Positron Emission Tomography Computed Tomography 2fluciclovine F-18 1abemaciclib 1Valproic Acid 1Tetrahydrouridine 1Sirolimus 1Positron-Emission Tomography 1Oncolytic Virotherapy 1Metformin 1Magnetic Resonance Imaging 1Lapatinib 1Ferrosoferric Oxide 1Fatty Acids, Omega-3 1BCG Vaccine 1Aminophylline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Urinary Bladder Neoplasms × Sirolimus × Clear all
NCT02753309 2021-03-19

A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed
33 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡